Cytokines in posterior uveitis: an update.

Area of Science:

• Immunology
• Ophthalmology

Background:

• T helper (Th) lymphocytes differentiate into Th1 and Th2 subsets, characterized by unique cytokine profiles and functional activities.
• Th1 cells secrete interferon-gamma (IFN-gamma), interleukin-2 (IL-2), and tumor necrosis factor-beta (TNF-beta), while Th2 cells produce interleukin-4 (IL-4), IL-5, IL-6, IL-9, and IL-13.
• These subsets are mutually antagonistic and play roles in the pathogenesis of posterior uveitis and experimental autoimmune uveitis (EAU).

Purpose of the Study:

• To review and evaluate studies investigating the uveitopathogenic and therapeutic potentials of Th1 and Th2 cytokines.
• To explore the role of cytokine profiles in the etiopathogenesis of posterior uveitis.
• To assess the potential therapeutic benefit of modulating Th1/Th2 responses in uveitis.

Main Methods:

• Literature review of studies examining Th1 and Th2 cytokines in the context of posterior uveitis and EAU.
• Analysis of cytokine profiles associated with Th1 and Th2 cell differentiation.
• Evaluation of research on the pathogenic and therapeutic roles of specific cytokines in uveitis models.

Main Results:

• Th1 and Th2 cells exhibit distinct cytokine profiles, functional properties, and activation markers.
• Th1 and Th2 cytokines are implicated in the pathogenesis of posterior uveitis and EAU.
• Evidence suggests a potential therapeutic advantage in shifting towards a Th2-dominated immune response in uveitis.

Conclusions:

• The balance of Th1 and Th2 cytokines is crucial in the pathogenesis of posterior uveitis.
• Modulating the Th1/Th2 immune response, particularly favoring a Th2-dominant profile, may represent a viable therapeutic strategy for uveitis.
• Further research is needed to fully define the contribution of these cytokine mediators to uveitis and to optimize therapeutic interventions.